OFFICIAL LEGAL TITLE
Expanding Access to Low-Cost Generics Act of 2021
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_S_2910.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2021-09-30.
What are the main provisions?
Key points include:
- Shortening the exclusivity period for initial generic drug manufacturers, paving the way for other companies.
- Allowing faster approval of cheaper drug alternatives if initial manufacturers do not bring them to market in a timely manner.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Smith, Tina [D-MN].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.